DB-1311

· DualityBio Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DB-1311, covering 2025-11-21 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors [Phase 2]